Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Up 700%, DexCom Stock Still Has Tons of Room To Run


Even with significant success over the past four years, DexCom (NASDAQ: DXCM) appears set to continue its growth in 2022 and beyond. In this segment of "The Earnings Show" on Motley Fool Live, recorded on Feb. 11, Fool contributors Taylor Carmichael and Brian Withers discuss the medical device company's encouraging outlook.

Continue reading


Source Fool.com

Like: 0
Share

Comments